Literature DB >> 4567314

The serum and conjunctival antibody response to trachoma in Gambian children.

L H Collier, J Sowa, S Sowa.   

Abstract

Ninety-nine young Gambian children were studied for 61 weeks. About half of them had trachoma at the outset, and 80% of the remainder acquired the disease while under observation. IgG trachoma antibody in the serum and IgG and IgA antibodies in the conjunctival secretions (CS) were titrated by an indirect immunofluorescence method. In serum samples obtained in capillary tubes the mean titre was slightly higher than in samples collected on filter paper. Serum antibody at titres >/= 1/10 was invariably associated with a clinical diagnosis of trachoma; it increased both in frequency and titre as the disease progressed, and was present in about half of those with Tr II. In CS, IgG antibody was present less often and at lower titres than in serum, and IgA antibody was detected even less frequently. There was some evidence of correlation between the titres of IgG and IgA antibodies in CS, but none for a relationship between the titres of the antibodies in serum and those in CS. Antibodies were almost never present in the absence of conjunctival follicles, but their titres were unrelated to the degree of follicular hyperplasia; there was no obvious relationship between the serological findings and corneal lesions. In children diagnosed clinically as trachoma, serum antibody was present in almost all those with conjunctival inclusions, and in a proportion of inclusion-negative subjects; the mean titre was much higher in the inclusion-positive group.These findings do not settle whether CS antibodies are made locally, or are derived partly or wholly from the blood. They suggest that the indirect immunofluorescence test may be a useful diagnostic aid in trachoma, particularly in view of the rarity of false positive reactions; but there is at present little to choose between it and complement-fixation tests in terms of sensitivity.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4567314      PMCID: PMC2130286          DOI: 10.1017/s0022172400022579

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  14 in total

1.  Assay of materials used in immunofluorescence techniques.

Authors:  W D Brighton
Journal:  J Clin Pathol       Date:  1966-09       Impact factor: 3.411

2.  Impurities in conjugated globulins for immunofluorescence techniques.

Authors:  W D Brighton; J E Lampard
Journal:  Immunology       Date:  1970-02       Impact factor: 7.397

3.  Studies on trachoma. 11. Evaluation of laboratory diagnostic methods under field conditions.

Authors:  M L Tarizzo; B Nabli; J Labonne
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

4.  The use of graded density filters made by photography in fluorescence microscopy.

Authors:  L H Collier
Journal:  J Pathol Bacteriol       Date:  1968-07

5.  The immunopathology of trachoma: some facts and fancies.

Authors:  L H Collier
Journal:  Arch Gesamte Virusforsch       Date:  1967

6.  Fluorescent antibodies in the fluid of the conjunctival sac of trachoma patients.

Authors:  H Bernkopf; J Orfila; B Maythar
Journal:  Nature       Date:  1966-02-12       Impact factor: 49.962

7.  Antibodies to trachoma in eye secretions of Saudi Arab children.

Authors:  D E McComb; R L Nichols
Journal:  Am J Epidemiol       Date:  1969-10       Impact factor: 4.897

8.  Trachoma vaccine field trials in The Gambia.

Authors:  S Sowa; J Sowa; L H Collier; W A Blyth
Journal:  J Hyg (Lond)       Date:  1969-12

9.  The radioisotope precipitation test for psittacosis group antibody.

Authors:  R K Gerloff; R O Watson
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

10.  Further classification of TRIC agents from ocular trachoma and other sources by the mouse toxicity prevention test.

Authors:  E R Alexander; S P Wang; J T Grayston
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

View more
  8 in total

1.  Serological studies on the role of Chlamydia in the aetiology of non-specific urethritis.

Authors:  P Reeve; R K Gerloff; E Casper; R N Philip; J D Oriel; P A Powis
Journal:  Br J Vener Dis       Date:  1974-04

2.  Chlamydial infection. Isolation of Chlamydia from patients with non-specific genital infection.

Authors:  J D Oriel; P Reeve; P Powis; A Miller; C S Nicol
Journal:  Br J Vener Dis       Date:  1972-12

3.  Serotypes of trachoma agent isolated in the Gambia: with an observation on the relation between serotype and morphology.

Authors:  J Sowa; L H Collier; S Sowa
Journal:  J Hyg (Lond)       Date:  1974-06

4.  Comparison of two immunofluorescence tests for detecting antibodies to C. trachomatis.

Authors:  T Forsey; K Stainsby; P H Hoger; G L Ridgway; S Darougar; U Fischer-Brugge
Journal:  Eur J Epidemiol       Date:  1986-06       Impact factor: 8.082

5.  Fluorescent antibody studies in chlamydial infections.

Authors:  S J Richmond; E O Caul
Journal:  J Clin Microbiol       Date:  1975-04       Impact factor: 5.948

6.  The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective.

Authors:  R L Bailey; M Kajbaf; H C Whittle; M E Ward; D C Mabey
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

7.  Immunohistochemical Analysis of Scarring Trachoma Indicates Infiltration by Natural Killer and Undefined CD45 Negative Cells.

Authors:  Victor H Hu; Philip J Luthert; Tamsyn Derrick; James Pullin; Helen A Weiss; Patrick Massae; Tara Mtuy; William Makupa; David Essex; David C W Mabey; Robin L Bailey; Martin J Holland; Matthew J Burton
Journal:  PLoS Negl Trop Dis       Date:  2016-05-24

8.  Genome-wide profiling of humoral immunity and pathogen genes under selection identifies immune evasion tactics of Chlamydia trachomatis during ocular infection.

Authors:  Harry Pickering; Andy Teng; Nkoyo Faal; Hassan Joof; Pateh Makalo; Eunice Cassama; Meno Nabicassa; Anna R Last; Sarah E Burr; Sarah L Rowland-Jones; Nicholas R Thomson; Chrissy H Roberts; David C W Mabey; Robin L Bailey; Richard D Hayward; Luis M de la Maza; Martin J Holland
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.